Erratum: Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer
L
Lujia Chen
Y
Ying Wang
C
Chunhui Cai
Y
Ying Ding
R
Rim S. Kim
C
Corey Lipchik
P
Patrick G. Gavin
G
Greg Yothers
(NRG Oncology SDMC, Pittsburgh, PA)
C
Carmen J. Allegra
N
Nicholas J. Petrelli
(Helen F. Graham Cancer Center and Research Institute, Christiana Care Health)
J
Jennifer Marie Suga
(Kaiser Permanente Vallejo Medical Center, Vallejo, CA)
J
Judith O. Hopkins
(Southeast Clinical Oncology Research Consortium and NCORP, Winston Salem, NC)
N
Naoyuki G. Saito
T
Terry Evans
S
Srinivas Jujjavarapu
N
Norman Wolmark
(University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh)
P
Peter C. Lucas
S
Soonmyung Paik
M
Min Sun
K
Katherine L. Pogue-Geile
X
Xinghua Lu
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 43, Issue 31
Published
November 01, 2025
Pages
3427-3427
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (21)
L
Lujia Chen
Y
Ying Wang
C
Chunhui Cai
Y
Ying Ding
R
Rim S. Kim
C
Corey Lipchik
P
Patrick G. Gavin
G
Greg Yothers
NRG Oncology SDMC, Pittsburgh, PA
C
Carmen J. Allegra
N
Nicholas J. Petrelli
Helen F. Graham Cancer Center and Research Institute, Christiana Care Health
J
Jennifer Marie Suga
Kaiser Permanente Vallejo Medical Center, Vallejo, CA
J
Judith O. Hopkins
Southeast Clinical Oncology Research Consortium and NCORP, Winston Salem, NC
N
Naoyuki G. Saito
T
Terry Evans
S
Srinivas Jujjavarapu
N
Norman Wolmark
University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
P
Peter C. Lucas
S
Soonmyung Paik
M
Min Sun
K
Katherine L. Pogue-Geile
X
Xinghua Lu
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001